Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration

In this page

Clinical Trial

NCT04796545 Recruiting, Active
Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration

A Prospective, Multicenter Post-marketing Clinical Investigation of the SING IMT(TM) System, Model NG SI IMT 3X in Patients With Central Vision Impairment Associated With End-stage Age-related Macular Degeneration

Interventional

Disease

Disease type

Other

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

13/09/2022

Closing date

31/12/2028

Inclusion criteria :

More

Exclusion criteria :

More

Funding

private

Members involved

Others investigators

Pr David KEEGAN

Representative

Ireland

Working Group Leader
See more

Pr Benedetto Falsini

Representative

Italy

See more

ERN EYE member investigating site

HCP : Principal investigators